REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Hg C.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorios Hg C.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Laboratorios Hg C.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on February 02, 1944. It currently has a total number of 207 (2024) employees. From the latest financial highlights, Laboratorios Hg C.A. reported a net sales revenue increase of 36.25% in 2024. During that time, Laboratorios Hg C.A.’s total assets grew by 25.02%.

Headquarters
Av. Domingo Comin 135
Guayaquil; Guayas;

Contact Details: Purchase the Laboratorios Hg C.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Hg C.A. report to view the information.
Registered Capital:
Purchase the Laboratorios Hg C.A. report to view the information.
Financial Auditors:
Purchase the Laboratorios Hg C.A. report to view the information.
Incorporation Date:
February 02, 1944
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
97.29%
Purchase this report to view the information.
2.71%
Subsidiaries
Imquilsa Imprenta Quil S.A. (IMQUILSA)
100%
Company Performance
Financial values in the chart are available after Laboratorios Hg C.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
36.25%▲
Total operating revenue
23.09%▲
Operating profit (EBIT)
3243.36%▲
EBITDA
2278.59%▲
Net Profit (Loss) for the Period
N/A
Total assets
25.02%▲
Total equity
6.36%▲
Operating Profit Margin (ROS)
13.8%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
55.65%▲
Quick Ratio
-0.49%▼
Cash Ratio
-0.15%▼

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Saleticlab S.A.
 
Jaspharm CIA Ltda
Cedimed CIA Ltda
 
Farmacid S.A.
Farmabion del Ecuador C.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo